Smart + Strong.
All Rights Reserved.
Smart + Strong®
is a registered trademark of CDM Publishing, LLC.
Puerto Rico’s economic crisis threatens critical progress on HIV.
The social media buzz on the annual HIV science conference.
The current situation for Puerto Ricans living with HIV on the island is yet again dire.
October/November 2017 Survey
Continued improvements in ARVs have likely further raised life expectancy for the average 20-year-old who starts treatment today.
The Food and Drug Administration recently approved a generic formulation of Gilead Sciences’ antiretroviral Truvada.
GNP+ works with communities of people living with HIV around the world to make sure their voices are heard.
Treating HIV early, before CD4s drop significantly, lowers the risk of infection-related cancers.
Researchers have found a new broadly neutralizing antibody against HIV. It is said to be safe, well tolerated and potent.
The National Alliance of State & Territorial AIDS Directors welcomes CDC-funded local jurisdictions. [VIDEO]
Researchers have used the cutting-edge CRISPR/Cas9 gene-editing technology to identify five potential targets for HIV treatments.
The country supplies generic meds to much of the world—but thanks to a new law, not for its own citizens living with HIV.
The FDA approved AZT in a record 20 months, a move that remains controversial today.
Find out about all the known risks, benefits, rights and responsibilities.
A commitment to fitness helps insure overall health.
Dispelling misconceptions about conception and HIV
You have been inactive for 60 minutes and will be logged out in . Any updates not saved will be lost.
Click here to log back in.